6379634

Source:http://linkedlifedata.com/resource/pubmed/id/6379634

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0030705, umls-concept:C0035608, umls-concept:C0041296
pubmed:issue	5
pubmed:dateCreated	1984-9-4
pubmed:language	ger
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7705449
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Rifampin
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0342-7498
pubmed:author	pubmed-author:JungbluthHH
pubmed:issnType	Print
pubmed:volume	38
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	177-81
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:6379634-Adult, pubmed-meshheading:6379634-Clinical Trials as Topic, pubmed-meshheading:6379634-Dose-Response Relationship, Drug, pubmed-meshheading:6379634-Drug Therapy, Combination, pubmed-meshheading:6379634-Female, pubmed-meshheading:6379634-Humans, pubmed-meshheading:6379634-Injections, Intravenous, pubmed-meshheading:6379634-Male, pubmed-meshheading:6379634-Rifampin, pubmed-meshheading:6379634-Tuberculosis, Pulmonary
pubmed:year	1984
pubmed:articleTitle	[Clinical trial with rifampicin i.v. 300 and 600 in tuberculosis patients].
pubmed:publicationType	Journal Article, Clinical Trial, English Abstract